Table 2.
Antimicrobial susceptibility of Vibrio harveyi with interpretation according to non-species related EUCAST breakpoints
| Antimicrobial agent | MIC (μg/ml) | Interpretation |
|---|---|---|
| Amikacin | 8 | |
| Amoxicillin | 16 | R |
| Ampicillin | 16 | R |
| Azithromycin | 2 | |
| Aztreonam | 2 | S |
| Ciprofloxacin | 0.125 | S |
| Ceftriaxon | 0.125 | S |
| Erythromycin | 4 | |
| Gentamicin | 1 | |
| Imipenem | 0.125 | S |
| Meropenem | 0.064 | S |
| Moxifloxacin | 0.25 | |
| Penicillin | > 32 | R |
| Piperacillin/Tazobactam | 0.125 | S |
| TMP/SMX | 0.032 | |
| Doxycycline | 0.25 | |
| Tobramycin | 2 | |
| Tetracyclin | 0.25 | |
| Streptomycin | 16 |
I intermediate, MIC minimum inhibitory concentration, R resistant, S susceptible, TMP/SMX trimethoprim/sulfamethoxazole